Overview

• Confederation of Indian Industry and Boston Consulting Group unveiled the report at the 17th CII Global MedTech Summit, where DoP secretary Amit Agrawal led the launch and flagged a planned Rs 5,000 crore PRIP scheme for research and innovation.
• The roadmap aligns with Viksit Bharat 2047, aiming to cut import dependence below 50% while expanding India’s roughly $16 billion market toward a 10–12% share of the global industry.
• The report calls for fine‑tuning the Production‑Linked Incentive scheme to boost MSME participation and for building a domestic ecosystem for critical raw materials.
• Nine recommended actions include rationalising duties on key inputs, attracting multinational manufacturing and R&D hubs, unlocking MedTech parks through co‑innovation labs and shared foundries, aligning regulations with global norms, and scaling advanced training hubs.
• Progress cited includes a drop in import reliance from about 80% in FY2022 to roughly 60% in FY2024, aided by incentives and MedTech parks such as the Andhra Pradesh MedTech Zone.